Navigation Links
Royalty Pharma Response To Elan's "Categorical View On Value"
Date:5/30/2013

NEW YORK, May 30, 2013 /PRNewswire/ -- Commenting on Elan's (NYSE: ELN) announcement of last night, Pablo Legorreta , Chief Executive Officer of Royalty Pharma, said: "In its announcement, Elan's Board makes the unrealistic claim that the Tysabri royalty it owns is worth between $6.1 billion and $6.6 billion*.  Elan shareholders should ask themselves, if this is true, why did Elan sell approximately half of the Tysabri economics that it owned to Biogen in February 2013 for $3.25 billion, 29% less than the $4.6 billion value implied by Royalty Pharma's offer, and 46% to 51% less than what the Elan Board is now claiming the other half is worth?  The only thing that has occurred since Elan's Tysabri sale to Biogen is the very successful launch of Biogen's competitive drug Tecfidera.  We will have further comment on Elan's valuation claims in the coming days."

*Based on Elan's value range for Tysabri of US$11.85-13.00 per share

J.P. Morgan, together with its affiliate J.P. Morgan Cazenove, BofA Merrill Lynch, together with its affiliate Merrill Lynch International, and Groton Partners are acting as financial advisers to Royalty Pharma.

Further information relating to the Increased Offer, including all announcements issued by or on behalf of Royalty Pharma, is available at www.royaltypharma.com

FURTHER INFORMATION
The distribution of this announcement in, into, or from, certain jurisdictions other than Ireland, the United Kingdom and the United States may be restricted or affected by the laws of those jurisdictions.  Accordingly, copies of this announcement are not being, and must not be, mailed or otherwise forwarded, distributed or sent in, into,
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Royalty Pharma Recommends Elan Shareholders vote "NO" on each of the Elan Resolutions at the Elan extraordinary general meeting
2. Royalty Pharma Issues Investor Presentation Highlighting The Strategic And Financial Advantages Of Its Offer To Acquire Elan For $12.50 Per Share In Cash
3. Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements
4. Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
5. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
6. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
7. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
8. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
9. PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
10. Royalty Pharma Announces Proposal To Acquire Elan
11. Royalty Rates Take Center Stage in Biopharma Dealmaking
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , December 17, 2014 Revenue and ... expenditure on research and development In the past ... revenue by two percent to EUR 4.287 billion (last year: ... by 14 percent to EUR 360 million. "Overall, 2013/14 was ... Michael Kaschke , President and CEO of Carl Zeiss ...
(Date:12/17/2014)...  Beamz Interactive, Inc. (OTCQB: BZIC), a leading ... that it has signed an agreement with RSL ... innovative prosthetic, orthotic and assistive technology products and ... RSL Steeper will promote and supply the Beamz ... within UK residential care facilities through its Assistive ...
(Date:12/17/2014)... Dec. 17, 2014  RXi Pharmaceuticals Corporation (NASDAQ: ... on discovering, developing and commercializing innovative therapies addressing ... completion of enrollment in its first Phase 2a ... observations confirmed the 1-month findings that were reported ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , ...
Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5
... , , LAKE MARY, Fla., Dec. 22 Access ... outsourced implantable medical device management solutions to the healthcare ... Partners in Focus online portal will be ... MediQuip provides implantable device management solutions that allow surgeries ...
... 22 Unilens Vision Inc. (OTC Bulletin Board: UVICF; TSX ... Vision Inc. voted overwhelmingly in favor of the resolution to ... of its shareholders held yesterday. Of the 2,361,854 common shares ... voted at the meeting with 1,141,138 (or 98.8%) voted in ...
Cached Medicine Technology:Access MediQuip Announces Release of Partners in Focus Provider Portal 2Unilens Announces Extraordinary Meeting Results 2
(Date:12/17/2014)... 17, 2014 A group of 127 scientists ... today, in reaction to a recent statement by the center ... training and derogated the efficacy of all brain exercises. , ... the parts of the center’s statement critical of brain exercise ... had also overstated its case, in a document it had ...
(Date:12/17/2014)... 2014 Project Veritas is releasing a ... of MIT economist and Obamacare architect Jonathan Gruber to ... conducted the interview, which is being distributed on YouTube. ... intentional mislabeling in the Affordable Care Act in order ... two-hundred-and-fifty billion dollar per year tax grab. , “President ...
(Date:12/17/2014)... -- Poor students get more fruits and vegetables at school ... But, the opposite is true for students from wealthier families. ... school may give a healthy boost to poor students, diets, ... family income level, students all ate a similar amount of ... study was published recently in the journal Preventive Medicine ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. ... in America, and work commitment is a big reason why, ... killer," said Dr. Mathias Basner, an assistant professor of sleep ... School of Medicine. A time-use survey of nearly 125,000 ... the main activity exchanged for sleep. Short sleepers -- those ...
(Date:12/15/2014)... Main Street Dental Team ( http://www.MainStreetDentalTeam.com ), Unionville’s first ... study providing evidence on the impact of 100% pure ... Sufficient enough evidence already exists showing a negative link ... with the onset of tooth decay. One question that ... 100% fruit juice, meaning it is completely natural with ...
Breaking Medicine News(10 mins):Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 3Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 4Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2Health News:Poor Students Eat Healthier Foods at School, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2
... Australia, Fremantle, for the patients with type II diabetes, the ... if they self-monitor their blood glucose levels. ,Dr. ... the journal Diabetes Care, explained that they conducted their study ... the Fremantle Diabetes Study. It was reported that a total ...
... in Toronto will begin on Sunday, bringing together over 20,000 ... play a more active role in the battle with this ... hard around the world especially in sub-Saharan Africa which is ... that nearly 9 out of 10 children diagnosed with HIV/AIDS ...
... new study published in the September issue of the ... identified the genes //responsible for preserving cognition even at ... of Pittsburgh are the first to identify the genetic ... has been defined in many ways, however, we focused ...
... expect far more from the children than their ... to a study that has been published in ... are increasingly being expected to provide an adult-level ... professor in McMaster University's Department of Psychology, Neuroscience ...
... diagnosed with prostate cancer three years ago is now ... Hospital. ,In a statement released by the Tannadice ... his illness were released putting an end to the ... ,The new treatment began at Ninewells Hospital ...
... workers against any pandemic or influenza outbreak, South Australia ... Mr. John Hill said//. The fund would assist in ... would be necessary to fight a potential influenza outbreak. ... the outbreak was uncontrollable, nearly 25% of South Australians ...
Cached Medicine News:Health News:Study Finds No Benefits On Self Monitoring Blood Glucose levels 2Health News:Church to Have an Active Role in the Prevention of AIDS 2Health News:Genes And Aging 2Health News:Please Give Kids a Break!! 2
Achievement, available exclusively from Art Optical, is a unique RGP lens design with a patented junctionless back surface and a controlled edge lift....
... is designed using sophisticated lathing techniques, intrinsically ... lenses feature a center thickness of just ... all plus powered Thinsite lenses maintain a ... designs. The unique design eliminates stress points ...
... is a simultaneous vision lens ... Through a series of front ... LifeStyle Gp delivers up to ... its multi-aspheric center-distance design works ...
Boston Multivision design is manufactured in Boston ES material for early presbyope patients. Boston Multivision lens provides crisp, clear vision at near, intermediate, and far distances and excelle...
Medicine Products: